BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Personalized medicine
,
Cisplatin
,
rs4950928
,
KLK3
,
Apoptosis
,
Diabetes mellitus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bullous dermatosis
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
ATP2C1
HLA-DRB1
KRT1
COL7A1
KRT75
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
JAEGER_METASTASIS_DN
FISCHER_DREAM_TARGETS
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
KOBAYASHI_EGFR_SIGNALING_24HR_DN
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
OMIM - Hailey-Hailey disease
OMIM - Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa
OMIM - Epidermolysis bullosa
Skin keratinocytes of Hailey-Hailey disease subjects with ATP2C1 mutation
OMIM - Ichthyosis
Explore Curated Studies Results
Literature
Most Relevant Literature
Linear IgA bullous dermatosis following Oxford AstraZeneca COVID-19 vaccine.
Ulcerative colitis complicated with linear immunoglobulin A bullous dermatosis.
Idiopathic linear IgA bullous dermatosis treated with prednisone.
A case of linear IgA bullous dermatosis localised on the genital area.
Neonatal Linear IgA Bullous Dermatosis Mediated by Breast Milk-Borne Maternal IgA.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Register of Autoimmune Bullous Dermatoses
Genetic Susceptibility and Influence of the Microbiomae in Bullous Pemphigoid
Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?
The Effects of Tildrakizumab in Treatment of Bullous Pemphigoid
Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBD…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ